Page last updated: 2024-10-29

iproniazid and Psoriasis

iproniazid has been researched along with Psoriasis in 5 studies

Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
WITTEN, VH1
SULZBERGER, MB1
MARCH, C1
DVORINE, W1
CHIAFITELLI, C1
BECKMAN, H1
SILVA, D1
ORSINI, O1

Other Studies

5 other studies available for iproniazid and Psoriasis

ArticleYear
Iproniazid therapy of psoriasis.
    Journal of the American Medical Association, 1959, Feb-07, Volume: 169, Issue:6

    Topics: Iproniazid; Isomerism; Niacin; Nicotinic Acids; Psoriasis

1959
[Use of iproniazid in the treatment of psoriasis].
    Hospital (Rio de Janeiro, Brazil), 1959, Volume: 55, Issue:5

    Topics: Humans; Iproniazid; Isomerism; Niacin; Nicotinic Acids; Psoriasis

1959
Some new ventures in systemic therapy for psoriasis.
    Wisconsin medical journal, 1960, Volume: 59

    Topics: Aminopterin; Iproniazid; Psoriasis; Triamcinolone

1960
[Clinical study of a case of psoriasis treated with iproniazid phosphate].
    Hospital (Rio de Janeiro, Brazil), 1959, Volume: 56

    Topics: Biomedical Research; Iproniazid; Phosphates; Psoriasis

1959
[Treatment of psoriasis with Nialamide].
    Hospital (Rio de Janeiro, Brazil), 1961, Volume: 60

    Topics: Iproniazid; Monoamine Oxidase Inhibitors; Nialamide; Psoriasis

1961